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Summary
Recently, independent lines ofevidence strongly suggested that peptides derived from one foreign
major histocompatibility complex (MHC) molecule bound to another MHC molecule can give
rise to multiple composite MHC complexes that are able to stimulate allo-(xeno)-reactive T cells.
In this study, we describe that in vivo immunization of mice with cells mismatched with the
recipient for a single class I antigen results in the induction of CD8 + cytotoxic T lymphocytes
(CTL) specific for allogeneic class I locus products (Dd, Kd, Dq) in the context of other class
I molecules (K5, Dd, Kk) present on stimulator cells. Evidently, the target antigen for these class
I-restricted alloreactive CTL is not the native classI molecule but peptides derived from endogenous
processing of allogeneic class I products presented by class I molecules. Using a combination
of limiting dilution and split-well analyses, we estimated for Kk-restricted Dq-specific alloreactive
CTL a precursor frequency (CTLpo that was -10 times lower than the CTLpf for "classical"
nonrestricted Dq-specific alloreactive CTL. These data suggest that H-2 class I peptides presented
by intact H-2 class I molecules are allostimulatory, supporting the concept that the capacity
for presentation ofMHC peptides by MHC molecules constitutes a part of the allogeneic immune
response.
V
irus-specific T cells recognize peptides derived from viral
proteins produced in the infected cell. These peptides
are presented by self-MHC class I or II molecules, as indi-
cated by functional (1, 2) and crystallographic data (3, 4).
Consequently, T cells recognize nominal antigens only on
cells expressing MHC molecules identical to those of the re-
sponder. This is in contrast to the apparently nonrestricted
recognition of alloantigens as alloreactive T cells recognize
MHC antigens on whichever cell.
Basedon the information that T cell recognition of nominal
antigens involves trimolecular interactions between receptors
on T cells, antigenic peptides, and class I or II MHC mole-
cules, several current models have been suggested to account
for allorecognition (reviewed in references 5-7) . From most
of the models, it appears that MHC alloreactivity probably
involves a tripartite structure consisting of an allogeneic MHC
molecule, an endogenous peptide, and a TCR. However, this
does not rule out that some alloreactive CTL may recognize
MHC molecules in the absence ofpeptide adducts, i.e., recog-
nizing "naked" class I MHC molecules (8). Recent studies
on alloreactivity also suggest that allogeneic responses include
the recognition of MHC peptides derived from one MHC
molecule and being presented to T cells by a second MHC
15
molecule (9-15). Additional examples of the presentation o£
MHC peptides by MHC molecules emerge from studies on
the xenogeneic response of murine T cells to human MHC
products (16-19). In some ofthese studies, CTL clones were
isolated for which the recognition of xenogeneic MHC pep-
tides was restricted by self-MHC, like the recognition of
nominal antigens (17). In other studies, the preferential binding
of xeno-MHC peptides by their native MHC molecules has
been suggested (20) .
Thus, at least a part of the MHC molecules on stimulator
and target cells might be occupied by derivatives of other
self-MHC molecules. An intriguing question emerging from
this concept is whether such composite MHC molecules play
a role in alloimmune response in vivo by the induction of
CTL specific for peptides derived from MHC alloantigens
and presented by other MHC molecules expressed either on
responder or stimulator cells. We report here that a subset
of CTL indeed recognized allogeneic classI MHC locus prod-
ucts in the context of other class I molecules. This popula-
tion of class I-restricted alloreactive CTL was detected only
afterin vivo priming at a frequency that was ti10 times lower
than the classical nonrestricted alloreactive CTL population.
These experiments suggest a further example of the capacity
J. Exp. Med. m The Rockefeller University Press - 0022-1007/91/07/0015/05 $2.00
Volume 174 July 1991 15-19of MHC molecules to present MHC peptides, and show that
allorecognition is a complex phenomenon in which multiple
T cell populations seem to play a role. The results might have
consequences for allogeneic transplantations in sensitized
recipients.
Materials and Methods
Mice.
￿
All mice were obtained from the Animal House of our
institute and bred under specific pathogen-free conditions. Mice
were primed by one intraperitoneal of 10' allogeneic spleen cells
in PBS 3-6 wk before use.
CTL Analysis.
￿
Limiting dilution (LD)l and split-well assays
have been described in detail elsewhere (21). Briefly, for split-well
analysis, 2,500 responder lymph node cells ofnaiveor primed mice
were cocultured with 50,000 irradiated (25 Gy) allogeneic spleen
cells per well in the presence of 20 U/ml rat IL2. For each split-
well experiment, 96 wells were seeded. After 7 d, microcultures
were divided into three (60-al) or four (45-Al) aliquots and trans-
ferred into wells containing 140 or 155 Al of medium and 5,000
"Cr-labeled target cells. Culture medium was IMDM sup-
plemented with 10% (wt/vol) FCS and 100 IU/ml penicilline, 100
hg/ml streptomycine, and 5 x 10-s M 2-ME. After 4 h of incu-
bation at 37°C, the supernatants were automatically harvested by
Titertek systems and counted in a gamma counter. Responding
cultures were defined as those in which the "Cr release values ex-
ceeded in the mean spontaneous "Cr release plus three times the
SD. LD cultures were set up starting from 64,000 to 500 responder
lymph node cells/well in 24 replicates. Stimulation, culture, and
"Cr release conditions, as well as the splitting of LD cultures into
four aliquots, were the same as for split-well analysis.
Target Cells.
￿
Spleen cells cultured for 3 d in the presence of
LPS (30 pl/ml) were used as target cells. Before labeling, target
cells were centrifuged on Ficoll. For blocking studies with H-2-
reactive antibodies, target cells were incubated with 100 1,1 of hy-
bridoma culture supernatant for 30 min at 37°C followed by the
same period on ice. Cells were washed twice with culture medium
before the addition of CTL. For blocking studies with anti-CD8,
target cells and CTL were incubated in the presence of 20 Al of
anti-CD8 antibodies(1:1,000). Antibodies used in this study were:
anti-Dq-(28.14.8S [22]), anti-Kk-(36.7.5S [23]), and anti-Ly2.2-
specific mAb (New England Nuclear, Boston, MA).
Calculation ofCTL Precursor Frequencies (CTLpf).
￿
CTLpf were
calculated by scoring wells with responding and nonresponding
cultures. Minimal estimates of CTLpf were calculated using the
jackknife version ofthe maximum likelihood procedure with a 95%
confidence interval determined according to the method described
by Strijbosch et al. (24). The correlation coefficient of the experi-
ments given was >0.90. Computer programs for the above-described
CTLpf calculations are available from the Computer Applications
Group (Tilburg University, Tilburg, The Netherlands).
Results and Discussion
To analyze whether a fraction of alloreactive CTL recog-
nize MHC alloantigens in the context of other MHC an-
tigens, we compared primary and secondary alloreactive CTL
responses of mice induced by a single H-2 class I difference.
1 Abbreviations used in this paper: CTLpf, cytotoxic Tlymphocyte precursor
frequencies; LD, limiting dilution.
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Because CTL bulk cultures are in general not restricted by
MHC, we generated CTL cultures at the level of precursor
frequency. For this propose, lymph node cellsfrom naive and
primed mice were stimulated in microcultures with allogeneic
spleen cells. Each microculture was split into three or four
aliquots and tested for cytotoxicity against selected target cells.
Table 1 shows the split-well analysis o£ three independent
experiments. Before priming, all CTL microcultures were reac-
tive with target cells expressing the stimulating class I H-2
antigen. Target cell lysis was not dependent on non-MHC
genes, i.e., background differences (Exp. 1) or coexpression
of other class I H-2 molecules on responder, stimulator, or
target cells (Exps. 1-3). These observations are general and
reported for a broad field ofclassical alloreactive CTL research.
After priming, the majority of respondingT cells exhibited
the same reactivity pattern. However, another population of
CTL lysed exclusively those target cells expressing in addi-
tion to the stimulating class I molecules, class I molecules
shared by both responder and stimulator cells. It appears that
after priming in vivo and restimulation in vitro, for a small
population of CTL, the recognition of the alloantigen is re-
stricted by syngeneic class I H-2 molecules. Obviously, rec-
ognition of alloantigens is restricted here by H-2 private de-
terminants. The percentage of H-2 class I-restricted alloreactive
CTL seems to be low, but it may well be that part of the
restricted CTL were overgrown by the classical non-MHC-
restricted alloreactive CTL. For that reason, we made an effort
to block target cell lysis by H-2-specific antibodies. To ensure
the involvement of CD8+ T cells, only those microcultures
were taken into account that were blocked by anti-CD8 an-
tibodies. Table 2 shows that 49 microcultures contained
CD8+ T cells reactive with the stimulator cells. Of these
49 cultures, 28 were blocked by anti-Dq antibodies, sug-
gesting a direct recognition of allogeneic D9 epitopes. 11
CTL microcultures were not blocked by anti-Dq but by Kk-
reactive antibodies. Here, the Kk molecule seems to be in-
volved in recognizing allogeneic Dq antigens. The peptide
model validfor nominal antigen recognition provides the best
model for explaining the specificity of the latter alloreactive
CTL. The recognized alloantigen seems to be formed by Kk
molecules associated with a class I peptide derived from Dq
molecules. The Kk molecules on the target cells (LPS blasts)
apparently contained sufficient amounts of Dq peptides to
be lysed by the CTL. Evidently, Dq molecules are processed
in the target cells and presented to Kk molecules by the en-
dogenous pathway of antigen presentation. Interactions on
the target cell membrane between T cell receptors and Kk
molecules associated with Dq peptides will be blocked by
Kk-reactive mAbs rather than by anti-Dq antibodies. Because
B10.BR and B10.AKM mice differ only in class I Dq or Kk
gene products, our findings suggest that a low percentage
of the syngeneic class I H-2 molecules is occupied with pep-
tides of other class I H-2 molecules. This has recently also
been shown in the human system for class I HLA molecules
of which the processed peptides were bound by HLA class
II expressed on the same cell surface (13, 15). Hence, endog-
enous processing and presentation of class I peptides normally
occurs in vitro and in vivo. However, our results in the mouse
Class I Antigens Recognized in the Context of Other Class I Moleculesmodel suggest that for class I molecules, peptide presenta-
tion is more efficient after sensibilization in vivo. Probably,
expression of the minimal number of MHC/peptide com-
plexes required for T cell activation is stimulated by priming
and differs from the number ofcomplexes necessary for target
cell lysis (25, 26).
Several other publications demonstrated that MHC class
I peptides can be recognized when presented by allogeneic
(9, 10) or xenogeneic (16, 17) MHC molecules or that such
peptides might inhibit allo- (11, 27) or xenoreactivity (28).
In this context, it is of interest to know at which frequency
CTL recognize such composite MHC antigens. Using a com-
bination of LD and split-well analysis, we estimated the fre-
quency of CTL precursors in lymph node cell populations
before and after sensitization to a single class I difference.
Table 3 shows that the frequency ofclassI-restricted alloreactive
CTL is -10 times lower than of the nonrestricted classical
alloreactive CTLp and that the majority of restricted CTL
is contributed by previously primed cells. Thus, in vivo im-
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Responder (R) lymph node cells of naive or primed mice were seeded into 96 wells (2,500/well) and cocultured with irradiated stimulator (S) spleen
cells (50,000/well). Microcultures were split into three or four aliquots and tested on SICr-labeled target cells in a final volume of 200 11. +, target
cell lysis; - , no target cell lysis.
" Expressed is the number out of 96 CTL microcultures exhibiting the indicated split-well pattern of target cell lysis.
munization with allogeneic classI molecules stimulates CTL
specific for composite determinants consisting of allogeneic
class I peptides presented by other class I molecules. Together
with the information that CTL are also able to recognize
class I peptides presented by class II molecules (13, 15), it
can be speculated that both class I and class II MHC mole-
cules present either class I- or class II-derived peptides. Re-
cently, it has been postulated that such complexes might play
a role in the determination of T cell repertoires (15) or in
T cell suppressor networks (29). Possibly, peptides derived
from one MHC gene product will bind to the intact prod-
ucts of the same gene (20) and may in this way participate
in elimination or inactivation of T cells with self-MHC
specificities.
Taken together, our results demonstrate that the recogni-
tion of allogeneic class I antigens is for a limited number of
CD8+ T cells restrictedby class I MHC molecules. The low
CTLpfsuggests that these restricted alloreactive CTL are only
a minor part of the totalT cell population and are therefore
Table 1. Split-well Analysis ofPrimary and Secondary Alloreactive CTL
H-2 Split-well reaction pattern of CTL microcultures
Exp. Mouse strain K D Before priming After priming
1
Responder A.SW s s
Stimulator A.TH s d
Target: 1 R
2 S
3 B10.D2 d d
4 B10.HTT s d
43` 0 49 7
2
Responder B10.BR k k
Stimulator B10.OH d k
Target: 1 S
2 B10.D2 d d
3 B10.GD d b
37 0 50 5
3
Responder B10.BR k k
Stimulator B10.AKM k q
Target: 1 S
2 B10.Q q q
3 B10.MBR b q
27 0 38 5Table 2.
￿
Split-well Analysis ofSecondary Allo{D9}reactive CTL
in the Presence of CD8- or H-2-specific mAbs
96 microcultures ofalloreactive CTL were seeded as indicated in thelegend
to Table 1. Lymph node cells of primed mice were used as responder
cells. +, blocking of target cell lysis;0, no blocking of target cell lysis.
Expressed is the number out of 96 CTL microcultures with the indi-
cated split-well pattern oftarget cell lysis.Targets were: stimulator cells
(1), stimulator cells in the presence of anti-CD8 mAbs (2), and stimu-
lator cells previously incubated with D9- (3) or Kk- (4) specific mAbs.
Table 3.
￿
Precursor Frequencies of Primary and Secondary Allo{D9}reactive CTL
noteasily detectable in CTL bulk cultures. Nevertheless, es-
pecially in those individuals who became sensitized to MHC
alloantigens, class I-restricted alloreactivity maybe involved
in the rejection of allogeneic grafts as allogeneic MHC class
I peptides are presented by class I molecules expressed on ei-
ther donor or recipient cells.
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Wellswere tested on responder (R), stimulator (S), and stimulator cells previously incubated with H-2-specific mAbs. Experiments are representative
and undependent examples.
` Reciprocal CTL precursor frequency.
t 95% Confidence interval.
s CTLpfwere estimated in individual mice by a combination of LD and split-well analysis.
II CTLpf and 95% CI are calculated using extrapolation to responder cell numbers not used in the LD assay.
H-2
K D
Split-well
reaction pattern of
CTL microcultures
Responder BIO.BR k k
Stimulator B10.AKM k q
Inhibition by:
1. - 0 0
2. Anti-CD8 + +
3. Anti-D9 + 0
4. Anti-Kk 0 +
38" 11
Exp.
Responder B10.BR
Stimulator B10.AKM
H-2K H-2D Frequency'
k k
k q
95% CIt
15 (before priming)
Targets: R 125,000 100,000-166,66711
S 3,788 2,759-5,528
S + anti-D9 89,909 63,407-95,95611
S + anti-Kk 4,409 3,667-8,657
2 (after priming)
Targets: R 99,997 66,667-166,66711
S 2,392 1,896-3,333
S + anti-D9 25,900 24,641-33,741
S + anti-Kk 3,185 2,463-4,685
3 (after priming)
Targets: R 86,878 66,667-166,66711
S 3,257 2,475-4,364
S + anti-D9 32,171 24,011-40,376
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